Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 287

Cited In for PubMed (Select 21212348)

1.

NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.

García-Cuesta EM, López-Cobo S, Álvarez-Maestro M, Esteso G, Romera-Cárdenas G, Rey M, Cassady-Cain RL, Linares A, Valés-Gómez A, Reyburn HT, Martínez-Piñeiro L, Valés-Gómez M.

Front Immunol. 2015 Jun 8;6:284. doi: 10.3389/fimmu.2015.00284. eCollection 2015.

2.

The Emerging Functions of Long Noncoding RNA in Immune Cells: Autoimmune Diseases.

Sigdel KR, Cheng A, Wang Y, Duan L, Zhang Y.

J Immunol Res. 2015;2015:848790. doi: 10.1155/2015/848790. Epub 2015 May 18. Review.

3.

Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.

Xu X, Li Y, Gauthier L, Chen Q, Vivier E, Mariuzza RA.

Acta Crystallogr F Struct Biol Commun. 2015 Jun 1;71(Pt 6):697-701. doi: 10.1107/S2053230X15006755. Epub 2015 May 20.

PMID:
26057798
4.

Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.

Gras Navarro A, Björklund AT, Chekenya M.

Front Immunol. 2015 Apr 29;6:202. doi: 10.3389/fimmu.2015.00202. eCollection 2015. Review.

5.

Utilizing chimeric antigen receptors to direct natural killer cell activity.

Hermanson DL, Kaufman DS.

Front Immunol. 2015 Apr 28;6:195. doi: 10.3389/fimmu.2015.00195. eCollection 2015. Review.

6.

Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.

Müller N, Michen S, Tietze S, Töpfer K, Schulte A, Lamszus K, Schmitz M, Schackert G, Pastan I, Temme A.

J Immunother. 2015 Jun;38(5):197-210. doi: 10.1097/CJI.0000000000000082.

PMID:
25962108
7.

Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles.

Pesce S, Carlomagno S, Moretta A, Sivori S, Marcenaro E.

J Immunol Res. 2015;2015:754373. doi: 10.1155/2015/754373. Epub 2015 Apr 16.

8.

Immunomodulatory effects mediated by serotonin.

Arreola R, Becerril-Villanueva E, Cruz-Fuentes C, Velasco-Velázquez MA, Garcés-Alvarez ME, Hurtado-Alvarado G, Quintero-Fabian S, Pavón L.

J Immunol Res. 2015;2015:354957. doi: 10.1155/2015/354957. Epub 2015 Apr 19. Review.

9.

First do no harm: uterine natural killer (NK) cells in assisted reproduction.

Moffett A, Shreeve N.

Hum Reprod. 2015 Jul;30(7):1519-25. doi: 10.1093/humrep/dev098. Epub 2015 May 7.

10.

Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.

Sato Y, Shimizu K, Shinga J, Hidaka M, Kawano F, Kakimi K, Yamasaki S, Asakura M, Fujii SI.

Oncoimmunology. 2015 Jan 22;4(3):e995541. eCollection 2015 Mar.

PMID:
25949922
11.

Analysis of GzmbCre as a Model System for Gene Deletion in the Natural Killer Cell Lineage.

Xu Y, Evaristo C, Alegre ML, Gurbuxani S, Kee BL.

PLoS One. 2015 Apr 29;10(4):e0125211. doi: 10.1371/journal.pone.0125211. eCollection 2015.

12.

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells.

Simhadri VR, Dimitrova M, Mariano JL, Zenarruzabeitia O, Zhong W, Ozawa T, Muraguchi A, Kishi H, Eichelberger MC, Borrego F.

PLoS One. 2015 Apr 27;10(4):e0124677. doi: 10.1371/journal.pone.0124677. eCollection 2015.

13.

NK cells require IL-28R for optimal in vivo activity.

Souza-Fonseca-Guimaraes F, Young A, Mittal D, Martinet L, Bruedigam C, Takeda K, Andoniou CE, Degli-Esposti MA, Hill GR, Smyth MJ.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2376-84. doi: 10.1073/pnas.1424241112. Epub 2015 Apr 21.

PMID:
25901316
14.

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus.

Ascierto ML, Bozzano F, Bedognetti D, Marras F, Schechterly C, Matsuura K, Picciotto A, Marenco S, Zhao Y, DeGiorgi V, Sommariva M, Moretta L, Wang E, Alter HJ, Marincola FM, De Maria A.

J Transl Med. 2015 Mar 1;13:77. doi: 10.1186/s12967-015-0428-x.

15.

Shed NKG2D ligand boosts NK cell immunity.

Narni-Mancinelli E, Vivier E.

Cell Res. 2015 Jun;25(6):651-2. doi: 10.1038/cr.2015.41. Epub 2015 Apr 7.

PMID:
25849247
16.

PLZF expression maps the early stages of ILC1 lineage development.

Constantinides MG, Gudjonson H, McDonald BD, Ishizuka IE, Verhoef PA, Dinner AR, Bendelac A.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5123-8. doi: 10.1073/pnas.1423244112. Epub 2015 Apr 2.

PMID:
25838284
17.

Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Larrubia JR, Moreno-Cubero E, Miquel J, Sanz-de-Villalobos E.

World J Gastroenterol. 2015 Mar 28;21(12):3480-91. doi: 10.3748/wjg.v21.i12.3480. Review.

18.

Maternal peripheral blood natural killer cells incorporate placenta-associated microRNAs during pregnancy.

Ishida Y, Zhao D, Ohkuchi A, Kuwata T, Yoshitake H, Yuge K, Takizawa T, Matsubara S, Suzuki M, Saito S, Takizawa T.

Int J Mol Med. 2015 Jun;35(6):1511-24. doi: 10.3892/ijmm.2015.2157. Epub 2015 Mar 27.

19.

Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function.

Deng Y, Kerdiles Y, Chu J, Yuan S, Wang Y, Chen X, Mao H, Zhang L, Zhang J, Hughes T, Deng Y, Zhang Q, Wang F, Zou X, Liu CG, Freud AG, Li X, Caligiuri MA, Vivier E, Yu J.

Immunity. 2015 Mar 17;42(3):457-70. doi: 10.1016/j.immuni.2015.02.006. Epub 2015 Mar 10.

PMID:
25769609
20.

Four crystal structures of human LLT1, a ligand of human NKR-P1, in varied glycosylation and oligomerization states.

Skálová T, Bláha J, Harlos K, Dušková J, Koval' T, Stránský J, Hašek J, Vaněk O, Dohnálek J.

Acta Crystallogr D Biol Crystallogr. 2015 Mar;71(Pt 3):578-91. doi: 10.1107/S1399004714027928. Epub 2015 Feb 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk